Renaissance Technologies - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$4,591
-39.8%
179,700
-32.4%
0.01%
-27.3%
Q2 2023$7,620
-99.2%
265,700
+895.6%
0.01%
+1000.0%
Q4 2021$988,000
-1.0%
26,687
-9.5%
0.00%0.0%
Q2 2021$998,000
-83.1%
29,500
-79.3%
0.00%
-85.7%
Q1 2021$5,898,000
+2231.2%
142,800
+512.9%
0.01%
Q4 2019$253,000
-24.3%
23,300
-28.3%
0.00%
Q3 2019$334,00032,5000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders